Preliminary studies available from The Jackson Laboratory website, and recently published studies (45), have shown that K18-hACE2 transgenic mice develop dose-dependent disease phenotypes when infected intranasally with SARS-CoV-2, with high doses resulting in ARDS/death analogous to that observed in some COVID-19 patients. This evidence concerns the gene KRT18 and COVID-19.